title: Non-cholinergic, trophic action of recombinant acetylcholinesterase on mid-brain dopaminergic neurons.
abstract: Acetylcholinesterase (AChE) is secreted from various brain regions such as the substantia nigra, where levels of this molecule are disproportionately higher than those of choline acetyltransferase. It is thus possible that AChE may have alternative, non-cholinergic functions, one of which could be in development. Indeed, several recent studies have already demonstrated a neurotrophic action of AChE independent of hydrolysis of acetylcholine. In the developing nervous system the dominant forms of AChE differ from the tetramers (G4) that prevail in maturity, in that they are lower molecular weight monomers (G1) and dimers (G2). Therefore, the aims of this study were to explore the neurotrophic role of AChE by comparing the effects of mouse recombinant G1 and G4 AChE on the survival and development of mid-brain tyrosine hydroxylase immunoreactive neurons. Butyrylcholinesterase (BuChE), which also hydrolyses acetylcholine, and basic fibroblast growth factor (bFGF), an established trophic factor for midbrain neurons, were also tested. bFGF had no significant stimulatory effect: moreover, BuChE was also inefficacious, suggesting that the action of AChE was independent of its catalytic site. In contrast, mouse recombinant G1 and G4 AChE both increased the survival as well as the outgrowth of the cultured neurons. However, G1 AChE was more potent than G4 AChE suggesting that developmental forms of AChE exist. The implications of this finding for physiological and pathological functioning of the nervous system are discussed.
authors.affiliation: University Department of Pharmacology, Oxford University, United Kingdom.
authors.forename: C
authors.initials: C
authors.lastname: Holmes
authors.forename: S A
authors.initials: SA
authors.lastname: Jones
authors.forename: T C
authors.initials: TC
authors.lastname: Budd
authors.forename: S A
authors.initials: SA
authors.lastname: Greenfield
mesh_terms: D000110:Acetylcholinesterase / Q000494:pharmacology*; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D016895:Culture Media, Serum-Free; D004298:Dopamine / Q000502:physiology*; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D008636:Mesencephalon / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology; D051379:Mice; D009414:Nerve Growth Factors / Q000494:pharmacology*; D009416:Nerve Regeneration / Q000187:drug effects; D009457:Neuroglia / Q000166:cytology / Q000187:drug effects; D009474:Neurons / Q000187:drug effects* / Q000201:enzymology; D011994:Recombinant Proteins / Q000494:pharmacology*; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis
chemical_list: D016895:Culture Media, Serum-Free; D009414:Nerve Growth Factors; D011994:Recombinant Proteins; D016222:Fibroblast Growth Factor 2; D014446:Tyrosine 3-Monooxygenase; D000110:Acetylcholinesterase; D004298:Dopamine